- Market Capitalization, $K 73,720
- Shares Outstanding, K 38,197
- Annual Sales, $ 0 K
- Annual Income, $ -114,760 K
- 60-Month Beta 1.13
- Price/Sales N/A
- Price/Cash Flow N/A
- Price/Book 1.21
|Period||Period Low||Period High||Performance|
| || |
-1.8100 (-49.05%)since 11/08/22
| || |
-3.4100 (-64.46%)since 09/08/22
| || |
-2.4800 (-56.88%)since 12/08/21
/PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced the succession...
Here is how IMARA Inc. (IMRA) and Viracta (VIRX) have performed compared to their sector so far this year.
The consensus price target hints at a 334.8% upside potential for Sunesis (VIRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate...
Viracta (VIRX) receives Orphan Drug designation from the European Commission for its lead candidate Nana-val for treating peripheral T-cell lymphoma. Stock up.
/PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that the...
Continued progress of NAVAL-1, the pivotal trial of Nana-val for the treatment of Epstein-Barr virus-positive (EBV+) lymphoma; update on the initial cohort(s)...
Viracta Therapeutics' (VIRX) Nana-val is being evaluated in multiple clinical studies in various subtypes of EBV-associated cancers.
Assertio Holdings' (ASRT) successful execution of its restructuring plan, resulting in significant cost savings, is boosting profits.
Chinook Therapeutics, Assertio Holdings, Viracta Therapeutics and Soleno Therapeutics are part of Zacks Industry Outlook article.
It is expected that innovation will continue to drive growth in the Medical-Drugs industry in 2022. KDNY, ASRT, VIRX, SLNO may prove to be good additions to one's portfolio.
|3rd Resistance Point||2.2367|
|2nd Resistance Point||2.1433|
|1st Resistance Point||2.0367|
|1st Support Level||1.8367|
|2nd Support Level||1.7433|
|3rd Support Level||1.6367|